SpyGlass Pharma, Inc. Common Stock

SGP XNAS • SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

690M

Short interest (Jul 15)

3.4%

Net Short (Jul 27 ): 0.0%

Borrow Fee

2.08%

↓ 10.1%

Available Shares

80K

↑ 24.2%

Price Chart

Company Overview

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Company Info

Exchange: NASDAQ

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

CIK: 0001778922

Asset Type: CS

Market Data

Market Cap: $685,049,443

Employees: 65

Status: Active

Short Interest

Current Borrow Fee 2.08%

Range: 2.08% - 2.75%

Available Shares 80K

Range: 10K - 85K

Recent Changes

Fee Change: ↓ 30.7%

Available Change: ↑ 40.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime